Transition Therapeutics (TTHI) Initiates ELND005 Phase 2 with First Dosing
Go back to Transition Therapeutics (TTHI) Initiates ELND005 Phase 2 with First Dosing| Elan Corp. PLC ADS (NYSE: ELN) | Delayed: 18.12 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.12 | 52 Week High | $18.21 | |||
| Open | $18.12 | 52 Week Low | $9.37 | |||
| Day High | $18.12 | P/E | N/A | |||
| Day Low | $18.12 | EPS | $0.00 | |||
| Volume | 100 | |||||
| Transition Therapeutics, Inc. (NASDAQ: TTHI) | Delayed: 1.52 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.52 | 52 Week High | $2.75 | |||
| Open | $0.00 | 52 Week Low | $0.66 | |||
| Day High | $1.52 | P/E | N/A | |||
| Day Low | $1.52 | EPS | $0.00 | |||
| Volume | 3,000 | |||||
